Skip to content
WaferGen Biosystems logo — company profile

WaferGen Biosystems

Founded 2002 United States Fremont, United States 21 employees Post-IPO Equity Total: $86.90M Biotechnology, Life Sciences +1

General Information

Company Name WaferGen Biosystems
Founded Year 2002
Location United States Fremont, United States
Employees 21
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with WaferGen Biosystems. To contact WaferGen Biosystems, visit wafergen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does WaferGen Biosystems compare?

A PDF of WaferGen Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting WaferGen Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About WaferGen Biosystems

WaferGen Biosystems is an innovative genomic analysis company founded in 2002 and headquartered in the United States. The company's flagship product is the advanced SmartChip Real-Time PCR System, which is designed for profiling and validation of gene expression patterns (biomarkers) on a single platform. This system offers high-throughput capabilities, including microRNA and mRNA gene expression profiling, and SNP genotyping. WaferGen Biosystems operates in the biotechnology, life sciences, and pharmaceutical industries.

The latest investment in WaferGen Biosystems amounted to $15.00M, in the form of a Post-IPO Equity investment on 27 August 2013.

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $15.00M -
27 Aug 2013
Post IPO Equity $30.55M -
01 Jun 2012
Post IPO Equity $30.00M 3
Great Point Partners, Merlin Nexus +1
31 May 2011
Post IPO Equity $5.09M -
24 Feb 2010
Post IPO Equity $6.26M -
15 Sep 2009

WaferGen Biosystems Alternatives & Competitors

View All Alternatives
WaferGen Biosystems vs
Texcell
Texcell France

Expert in viral safety since 1987.

112 employees
Life Sciences, Pharmaceutical
WaferGen Biosystems vs
LUMICKS
LUMICKS The Netherlands

See more. Know more.

Debt Financing
123 employees
Biotechnology, Life Sciences
WaferGen Biosystems vs

RNA expression like you've never seen before

Series C
143 employees
Biotechnology, Health Care

FAQ About WaferGen Biosystems

NOW PART OF TAKARA BIO USA, INC. -- Please visit the Takara Bio USA, Inc. company page for the latest updates: https://www.linkedin.com/company-beta/17509/ WaferGen automation systems include innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8® Sing...
WaferGen Biosystems was founded in 2002.
WaferGen Biosystems is headquartered in Fremont, United States.
WaferGen Biosystems operates in Biotechnology, Life Sciences and Pharmaceutical.
WaferGen Biosystems has approximately 21 employees.
WaferGen Biosystems has completed 5 funding rounds, raising a total of $86.90M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to WaferGen Biosystems include Texcell, LUMICKS, Advanced Cell Diagnostics (ACD), Sage Science, Inc., Genprex, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WaferGen Biosystems and Texcell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WaferGen Biosystems, https://bouncewatch.com/company/wafergen-biosystems, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout